Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
23 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Zhejiang Jingxin Pharmaceutical Co., Ltd (Jingxin Pharma) is a pharmaceutical company that manufactures and markets traditional Chinese medicine. The companys product portfolio includes finished dosage forms, Chinese herbal drugs and APIs. Its finished dosage products include simvastatin tablets, lovastatin capsules, fenofibrate capsules (ii), gliclazid tablets, cilnidipine capsules, sertraline hydrochloride dispersing tablets, sertraline hydrochloride tablets, cisapride tablets, and ciprofloxacin hydrochloride capsules.

Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal fina

  
Source:
Document ID
GDPH139166D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Zhejiang Jingxin Pharmaceutical Co., Ltd, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Zhejiang Jingxin Pharmaceutical Co., Ltd, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Zhejiang Jingxin Pharmaceutical Co., Ltd, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Zhejiang Jingxin Pharmaceutical Co., Ltd, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201682
Zhejiang Jingxin Pharmaceutical Co., Ltd, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Zhejiang Jingxin Pharmaceutical Co., Ltd, Pharmaceuticals &Healthcare, Deal Details119
  Licensing Agreements111
    Evotec Technologies Enters Into Licensing Agreement With Zhejiang Jingxin Pharma For EVT 201112
  Equity Offering131
    Zhejiang Jingxin Pharma Terminates Private Placement of Shares for USD182.5 Million132
    Mapi Pharma to Raise USD10 Million in Private Placement of Shares151
    Zhejiang Jingxin Pharma Announces Private Placement Of Shares For US$82 Million161
    Zhejiang Jingxin Pharma Announces Private Placement To Raise US$70.3 Million171
  Acquisition181
    Zhejiang Jingxin Pharma to Acquire 51% Stake in Pharmula Labs181
    Zhejiang Jingxin Pharma To Acquire Beijing Shunda Sihai Bio-Pharma From Zhang Shouzhen191
Zhejiang Jingxin Pharmaceutical Co., Ltd - Key Competitors201
Key Employees211
Locations And Subsidiaries221
  Head Office221
Appendix231
  Methodology231
  About GlobalData231
  Contact Us231
  Disclaimer231

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zhejiang-Jingxin-Pharmaceutical-Co-Ltd-002020-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7854>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zhejiang-Jingxin-Pharmaceutical-Co-Ltd-002020-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7854>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research